ABO blood groups in relation to biomarkers of vascular structure and function in young, healthy adults – the LBA study
- 1Department of Medical Biosciences, Clinical Chemistry, Umeå University, Umeå, Sweden
- 2Department of Laboratory Medicine, Clinical Chemistry, Örebro University Hospital, Örebro, Sweden
- 3School of Medicine, Faculty of Medicine and Health, Örebro University, Örebro, Sweden
Abstract
Background: In the elderly, ABO blood groups influence the risk of cardiovascular and thrombotic events, with blood group O consistently showing a more favorable risk profile. However, whether these differences affect physiological markers of vascular structure or subclinical metabolic traits in early adulthood remains poorly studied.
Methods: In this cross-sectional study, cardiovascular disease-related biomarkers in serum, measures of vascular structure and function, pulse-wave velocity (PWV), augmentation index (AIx), carotid intima-media thickness (cIMT), and ABO blood groups were assessed in a sample of young, healthy subjects aged 18–26 years.
Results: No statistically significant differences in PWV, AIx, or cIMT were identified across the different ABO blood groups. Conversely, the serum biomarkers showed distinct profiles. Individuals with blood group O presented with lower plasma concentrations of von Willebrand factor (vWF) compared to all non-O carriers (0.84 kIE/L vs. non-O, 1.09 kIE/L, p < 0.05). Furthermore, blood group O carriers demonstrated significantly lower fasting plasma glucose levels (4.96 mmol/L vs. 5.02 mmol/L, p = 0.02) and a trend toward lower fasting serum insulin levels (p = 0.07).
Conclusion: ABO blood groups were not associated with measures of vascular structure and function in young, healthy adults. Non-O blood groups were associated with higher vWF levels and altered glucose metabolism, suggesting that circulating cardiometabolic risk markers vary by blood group early in life.
Related
- Dietary and Circulating Advanced Glycation End Products in Relation to Inflammation and Cognitive Function in Healthy Young Adults
- Early Structure–Function Correlates in Neovascular Age-Related Macular Degeneration Using Artificial Intelligence–Derived OCT Biomarkers
- CSF Alzheimer's Disease Biomarkers in Relation to Functional Status and Tofersen Treatment Response in ALS
- The role of vascular resistance on coronary perfusion: differences between healthy and anomalous coronary origin under rest and exercise conditions
- Physical and lifestyle predictors of vascular function in postmenopausal East Asian women: the women’s vascular health project
BibTeX
@article{stefansson2026blood,
title = {{ABO blood groups in relation to biomarkers of vascular structure and function in young, healthy adults – the LBA study}},
author = {Kristina Stefansson and Gurdeep Chahal and Johan Hultdin and Torbjörn K. Nilsson and Paul Pettersson-Pablo},
journal = {BMC Cardiovascular Disorders},
year = {2026},
month = oct,
doi = {10.1186/s12872-026-06924-0},
url = {https://doi.org/10.1186/s12872-026-06924-0},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - ABO blood groups in relation to biomarkers of vascular structure and function in young, healthy adults – the LBA study
AU - Kristina Stefansson
AU - Gurdeep Chahal
AU - Johan Hultdin
AU - Torbjörn K. Nilsson
AU - Paul Pettersson-Pablo
PY - 2026
DA - 2026/10/27
JO - BMC Cardiovascular Disorders
DO - 10.1186/s12872-026-06924-0
UR - https://doi.org/10.1186/s12872-026-06924-0
AB - Background: In the elderly, ABO blood groups influence the risk of cardiovascular and thrombotic events, with blood group O consistently showing a more favorable risk profile. However, whether these differences affect physiological markers of vascular structure or subclinical metabolic traits in early adulthood remains poorly studied. Methods: In this cross-sectional study, cardiovascular disease-related biomarkers in serum, measures of vascular structure and function, pulse-wave velocity (PWV), augmentation index (AIx), carotid intima-media thickness (cIMT), and ABO blood groups were assessed in a sample of young, healthy subjects aged 18–26 years. Results: No statistically significant differences in PWV, AIx, or cIMT were identified across the different ABO blood groups. Conversely, the serum biomarkers showed distinct profiles. Individuals with blood group O presented with lower plasma concentrations of von Willebrand factor (vWF) compared to all non-O carriers (0.84 kIE/L vs. non-O, 1.09 kIE/L, p < 0.05). Furthermore, blood group O carriers demonstrated significantly lower fasting plasma glucose levels (4.96 mmol/L vs. 5.02 mmol/L, p = 0.02) and a trend toward lower fasting serum insulin levels (p = 0.07). Conclusion: ABO blood groups were not associated with measures of vascular structure and function in young, healthy adults. Non-O blood groups were associated with higher vWF levels and altered glucose metabolism, suggesting that circulating cardiometabolic risk markers vary by blood group early in life.
SN - 1471-2261
ER -